Skip to main content

Table 10 Determination of ESP and NAP in marketed samples

From: Analytical quality by design approach to RP-HPLC method development and validation for simultaneous estimation of esomeprazole and naproxen in modified-release dosage form

Generic brands

ESP

NAP

Label amount (mg)

Observed amount (mg)

Assay (%)

Label amount (mg)

Observed amount (mg)

Assay (%)

B-1

20.00

21.71

108.55

500.00

504.70

100.94

B-2

20.00

19.82

99.08

500.00

514.95

102.99

B-3

20.00

21.50

107.49

500.00

518.57

103.71